Biopsy News and Research

RSS

Biopsy is the removal of cells or tissues for examination by a pathologist. The pathologist may study the tissue under a microscope or perform other tests on the cells or tissue. There are many different types of biopsy procedures. The most common types include: (1) incisional biopsy, in which only a sample of tissue is removed; (2) excisional biopsy, in which an entire lump or suspicious area is removed; and (3) needle biopsy, in which a sample of tissue or fluid is removed with a needle. When a wide needle is used, the procedure is called a core biopsy. When a thin needle is used, the procedure is called a fine-needle aspiration biopsy.

Gold nanoparticles used successfully in prostate tumour trial

Researchers at the Icahn School of Medicine, Mount Sinai, New York have reported a pilot clinical trial with a “nanoparticle-based photothermal cancer therapy” for prostate cancers. Their work with this targeted therapy is published in a study titled, “Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study,” in the latest issue of the journal Proceedings of National Academy of Science.

28 Aug 2019

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Biocompatible gold nanoparticles designed to convert near-infrared light to heat have been shown to safely and effectively ablate low- to intermediate-grade tumors within the prostate, according to a study conducted at the Icahn School of Medicine and published in the journal Proceedings of the National Academy of Sciences.

27 Aug 2019

Hybrid tubes with external thread to improve tissue sample storage

Designed with special features for the storage of fresh frozen tissue samples, Micronic releases the innovative and traceable 1.50 ml and 3.00 ml Hybrid tubes with external thread.

From Micronic 26 Aug 2019

Simple test could help diagnose glioblastoma

Scientists at the University of Sussex could be a step closer to developing the first-ever blood test to diagnose the most aggressive type of brain cancer, glioblastoma.

20 Aug 2019

Targeted pancreatic cancer drug shows promise in clinical trials

Researchers have conducted clinical trials with a new drug targeting pancreatic cancer and the initial results are promising.

16 Aug 2019

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park Comprehensive Cancer Center researchers have received more than a dozen recent grant awards totaling more than $15.4 million.

14 Aug 2019

Researchers describe histological features of urinary obstruction in humans for the first time

A research group from the Medical University of Vienna has successfully described the histological features of urinary obstruction in humans the first time.

13 Aug 2019

AI system could help better detect and diagnose breast cancer

UCLA researchers have developed an artificial intelligence system that could help pathologists read biopsies more accurately and to better detect and diagnose breast cancer.

12 Aug 2019

Advanced imaging technology for prostate cancer could increase a man’s chances of survival

According to the American Cancer Society, approximately one in nine men will be diagnosed with prostate cancer in their lifetime.

9 Aug 2019

A TARDIS could vastly improve detection of breast cancer

Scientists have devised a newer form of blood test called TARDIS to diagnose breast cancer more accurately. This could help many thousands of women avoid needless breast biopsies and removals, as well as helping to follow up the treatment of breast cancer.

8 Aug 2019

New 'liquid biopsy' blood test for breast cancer could help avoid unnecessary surgeries

A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute and Mayo Clinic in Arizona.

7 Aug 2019

Blood clotting proteins in urine act as potent biomarkers for lupus

The team of researchers at the University of Houston found that blood clotting proteins, both the ones that promote blood clotting (prothrombic) and those that disperse them (thrombolytic) are elevated in the urine of patients with lupus nephritis (LN).

7 Aug 2019

Researchers discover blood clotting proteins in urine as biomarkers of lupus nephritis

University of Houston researcher Chandra Mohan is reporting in Arthritis Research and Therapy that clotting proteins, both those that promote blood clots (pro-thrombotic) and those that work to dissipate them (thrombolytic), are elevated in the urine of patients who suffer from lupus nephritis (LN).

7 Aug 2019

Highly sensitive blood test may help doctors tailor better breast cancer treatments

A new, highly sensitive blood test is one of the first to successfully monitor breast cancer patients with early stage disease and could be up to 100 times more sensitive than existing tests, according to a study published in Science Translational Medicine today (Wednesday).

6 Aug 2019

New blood test can detect clinically significant prostate cancer in high-risk patients

An international research team at Mahidol University in Bangkok, Thailand, has developed a new blood test capable of detecting clinically significant prostate cancer in high-risk patients, as reported in the medical journal Cancers on 27 July 2019.

6 Aug 2019

Biomarkers reveal increase in thyroid cancer incidence among WTC responders

The incidence of thyroid cancer among first responders who volunteered or were employed as firefighters, rescue personnel and cleanup workers at Ground Zero in New York on or after September 11, 2001, is three times higher than that in the general population.

5 Aug 2019

MSI detection in blood samples can guide treatment planning for patients with advanced cancer

Incorporation of pan-cancer microsatellite instability (MSI) detection into the 74-gene panel Guardant360 liquid biopsy assay showed high concordance with matched tissue samples in nearly 1,000 patients.

5 Aug 2019

Scientist wins two-year grant for diagnosis of Alzheimer's, Parkinson's via innovative skin test

Wenquan Zou, MD, PhD, an expert in prion and degenerative neurological diseases, has received a two-year grant for developing diagnostic tools for Alzheimer's disease, Parkinson's disease, and other related brain-based degenerative disorders via an innovative skin test that uses ultrasensitive technology.

2 Aug 2019

New biomarker can identify patients with symptoms of kidney rejection

A group of European scientists led by KU Leuven has found a biomarker that can identify patients with symptoms of kidney rejection symptoms after a transplant as a result of antibodies.

2 Aug 2019

Preliminary study for detection of pancreatic cancer shows encouraging results

OTraces, Inc., a molecular diagnostics company specializing in early cancer detection, has announced completion of a preliminary study for detection of pancreatic cancer.

1 Aug 2019

Biopsy News and Research

Further Reading

Gold nanoparticles used successfully in prostate tumour trial

Gold nanoparticles shown to safely, effectively ablate low- to intermediate-grade prostate tumors

Hybrid tubes with external thread to improve tissue sample storage

Simple test could help diagnose glioblastoma

Targeted pancreatic cancer drug shows promise in clinical trials

Roswell Park receives more than $15 million in grants for cancer research

Researchers describe histological features of urinary obstruction in humans for the first time

AI system could help better detect and diagnose breast cancer

Advanced imaging technology for prostate cancer could increase a man’s chances of survival

A TARDIS could vastly improve detection of breast cancer

New 'liquid biopsy' blood test for breast cancer could help avoid unnecessary surgeries

Blood clotting proteins in urine act as potent biomarkers for lupus

Researchers discover blood clotting proteins in urine as biomarkers of lupus nephritis

Highly sensitive blood test may help doctors tailor better breast cancer treatments

New blood test can detect clinically significant prostate cancer in high-risk patients

Biomarkers reveal increase in thyroid cancer incidence among WTC responders

MSI detection in blood samples can guide treatment planning for patients with advanced cancer

Scientist wins two-year grant for diagnosis of Alzheimer's, Parkinson's via innovative skin test

New biomarker can identify patients with symptoms of kidney rejection

Preliminary study for detection of pancreatic cancer shows encouraging results

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News